Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE3
Multi-dose-escalation Safety and Pharmacokinetic Study of SAR3419 as Single Agent in Relapsed/Refractory B-cell Non Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders
- Status
- COMPLETED
- Phase
- NA
Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
High-Dose Chemotherapy in Treating Patients Undergoing Stem Cell Transplant for Recurrent or Refractory Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- NA
Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment
- Status
- COMPLETED
- Phase
- PHASE1
PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- Status
- COMPLETED
- Phase
- NA
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- N/A
Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Disseminated High Grade Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- NA
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Non-Myeloablative Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Dalteparin in Preventing DVT in Participants With Cancer
- Status
- COMPLETED
- Phase
- NA
Phase I Trial of PX-478
- Status
- COMPLETED
- Phase
- PHASE1